ARTICLE | Company News
CalciMedica, TorreyPines deal
October 20, 2008 7:00 AM UTC
CalciMedica exercised an option under a 2007 deal with TorreyPines to acquire IP related to the use of stromal interaction molecule-1 (STIM-1) and Ca release-activated Ca ( CRAC) channel inhibitors to...